A new reagent for the induction of T-cell depletion, anti-CD3-CRM9

J Immunother Emphasis Tumor Immunol. 1996 Mar;19(2):85-92. doi: 10.1097/00002371-199603000-00001.

Abstract

We have developed a new reagent for inducing in vivo T-cell depletion and have tested this reagent in rhesus monkeys. The reagent is an anti-CD3 epsilon immunotoxin based on a diphtheria toxin binding-site mutant, CRM9. After administration to monkeys, T cells are depleted from both the blood and lymph node compartments to < 1% of their initial values. T-cell depletion is associated with transient immunosuppression, as judged by delayed rejection of RhLA-mismatched skin allografts. T cells are repopulated in both compartments; however, the rate of repopulation is age dependent. The rate is rapid in juvenile animals (12 days) and requires > 30 days in old animals. The correlation between repopulation rate and age suggests that the repopulation is thymus dependent and that the repopulated T cells are probably naive T cells. This reagent should be a valuable tool in studying the role of memory T cells in rhesus models of autoimmune diseases and protocols of tolerance induction after organ transplantation.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • Antitoxins / biosynthesis
  • CD3 Complex / immunology*
  • Diphtheria Toxin / genetics
  • Diphtheria Toxin / immunology*
  • Graft Survival / immunology
  • Humans
  • Immunotoxins / pharmacology*
  • Indicators and Reagents
  • Lymphocyte Activation / drug effects*
  • Lymphocyte Depletion / methods*
  • Macaca mulatta
  • Protein Binding / immunology
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Monoclonal
  • Antitoxins
  • CD3 Complex
  • Diphtheria Toxin
  • Immunotoxins
  • Indicators and Reagents